Skip to main content
padlock icon - secure page this page is secure

Cholesteryl Ester Transfer Protein (CETP) Inhibitors

Buy Article:

$68.00 + tax (Refund Policy)

Epidemiological studies have demonstrated an inverse correlation between plasma concentrations of highdensity lipoprotein cholesterol (HDL-C) and incidence of coronary heart disease (CHD); thus new therapies for raising HDL-C levels have been the focus of significant efforts by the cardiovascular medicine community. Inhibition of cholesteryl ester transfer protein (CETP) is one approach to increasing HDL-C concentrations. CETP is a plasma glycoprotein that mediates the transfer of cholesteryl esters from HDL to the apoB-containing lipoproteins, with a balanced transfer of triglycerides. Inhibition of CETP results in an accumulation of cholesteryl esters in HDL, thus resulting in increased HDL-C. Pharmacological inhibition of CETP in humans has been shown to result in increased levels of HDL-C, although any beneficial effect of this inhibition on CHD has yet to be established. This review article will discuss the complex role of CETP in lipid metabolism, recent developments for small-molecule inhibitors of CETP, and future prospects for CETP inhibitors in the treatment of CHD.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Atherosclerosis; CETP inhibitor; cholesteryl ester transfer protein; coronary heart disease; high-density lipoprotein cholesterol; low-density lipoprotein cholesterol

Document Type: Research Article

Affiliations: Merck Research Laboratories, RY800-C307, P.O. Box 2000, Rahway, NJ 07065, USA.

Publication date: April 1, 2009

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more